Fenoglide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Shore Therapeutics, Inc. The primary component is Fenofibrate.
Product ID | 52725-490_986c60c0-7d75-11e0-b654-0002a5d5c51b |
NDC | 52725-490 |
Product Type | Human Prescription Drug |
Proprietary Name | Fenoglide |
Generic Name | Fenofibrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-11-18 |
Marketing Category | NDA / NDA |
Application Number | NDA022118 |
Labeler Name | Shore Therapeutics, Inc |
Substance Name | FENOFIBRATE |
Active Ingredient Strength | 40 mg/1 |
Pharm Classes | Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2010-11-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022118 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-11-18 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
FENOFIBRATE | 40 mg/1 |
SPL SET ID: | b38489c0-ee7b-11df-b958-0002a5d5c51b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
68012-490 | Fenoglide | Fenoglide |
68012-495 | Fenoglide | Fenoglide |
52725-490 | Fenoglide | Fenoglide |
52725-495 | Fenoglide | Fenoglide |
0093-7755 | Fenofibrate | Fenofibrate |
0093-7756 | Fenofibrate | Fenofibrate |
0115-0511 | Fenofibrate | FENOFIBRATE |
0115-0522 | Fenofibrate | FENOFIBRATE |
0115-0533 | Fenofibrate | FENOFIBRATE |
0115-1522 | Fenofibrate | Fenofibrate |
0115-1523 | Fenofibrate | Fenofibrate |
0115-5511 | FENOFIBRATE | FENOFIBRATE |
0115-5522 | FENOFIBRATE | FENOFIBRATE |
0074-3173 | Tricor | Fenofibrate |
0074-3189 | Tricor | Fenofibrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FENOGLIDE 77381746 3528941 Live/Registered |
SANTARUS, INC. 2008-01-28 |